Autism Spectrum Disorder (ASD)

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Plus Therapeutics
1 program
Continuous Theta Burst Stimulation to Bilateral DLPFCN/A1 trial
Active Trials
NCT07182331Enrolling By InvitationEst. Jun 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Plus TherapeuticsContinuous Theta Burst Stimulation to Bilateral DLPFC

Clinical Trials (1)

NCT07182331Plus TherapeuticsContinuous Theta Burst Stimulation to Bilateral DLPFC

Brain Stimulation and Sensory Integration in Children With ASD

Start: Aug 2025Est. completion: Jun 2026
N/AEnrolling By Invitation

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space